Mikhail Groubman

Mikhail Groubman is a seasoned professional with extensive experience in the pharmaceutical and clinical research sectors. As Co-Founder of Lagopharm since August 2016, Mikhail has been responsible for the company's creation, management, and long-term strategic development, leading to significant revenue achievements exceeding 1 billion. Additionally, in the role of CEO at Atlant Clinical since June 2012, Mikhail has overseen general management, strategic planning, and successful company transformation, including a remarkable 10X revenue growth in seven years and the establishment of ISO9001:2015 certification as the first in Russia for clinical trial management. Earlier career experiences include serving as Market Access Director at Raifarm and various roles at GlaxoSmithKline, culminating in a Regional Market Access Director position. Mikhail holds a Master's in Management (Marketing) and a Specialist degree in Biochemistry from Lomonosov Moscow State University.